156
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Neu (C-erbB-2) Oncogene in Breast Cancer and its Possible Association with the Risk of Distant Metastases a Retrospective Study and Review of Literature

, , , &
Pages 931-934 | Received 31 Jul 1989, Accepted 22 Jan 1990, Published online: 08 Jul 2009

References

  • Slamon D J, Clark G M, Wong S G, Levin W J, Ullrich A, McGuire W L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–81
  • Bishop J M. The molecular genetics of cancer. Science 1987; 235: 305–10
  • Slamon D J, Godolphin W, Jones L A, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707–12
  • Baltimore D. The impact of the discovery of oncogenes on cancer mortality will come slowly. Cancer 1987; 34: 1985–6
  • Fontaine J, Tesseraux M, Klein V, Bastert G, Blin N. Gene amplification and expression of the neu (C-erbB-2) sequence in human mammary carcinoma. Oncology 1988; 45: 360–3
  • Shih C, Padhy L, Murray M, Weinberg R A. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 1981; 290: 261–3
  • Schechter A L, Hung M C, Vaidyanathan L. The neu oncogene: and erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 1985; 229: 976–8
  • Maguire H C, Greene I, Jr., Greene M I. The neu (C-erbB-2) oncogene. Oncology 1989; 16: 148–55
  • Bargmann C I, Hung M C, Weinberg R A. The neu oncogene encodes on epidermal growth factor receptor related protein. Nature 1986; 319: 226–30
  • Bargmann C I, Hung M C, Weinberg R A. Multiple independant activations of the neu oncogene by a point mutation altering the transmembrane domains of p-185. Cell 1986; 45: 649–57
  • Zhou D, Battirora H, Yokata J, Yamamato T, Cline M J. Association of multiple copies of the C-erbB-2 oncogene with spread of breast cancer. Cancer Res 1987; 47: 6123–5
  • Yokota J, Terada M, Toyoshima K, et al. Amplification of the C-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet 1986; 1: 765–7
  • Van den Vijver M J, Mooi W J, Peterse J L, Nusse R. Amplification and over-expression of the neu oncogene in human breast carcinomas. Eur J Surg Oncol 1988; 14: 111–4
  • Cline M J, Battifora H, Yokota J. Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease. J Clin Oncol 1987; 5: 999–1006
  • Yamamoto T, Kamata N, Kawano H. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 1986; 46: 414–6
  • Likermann T A, Razon N, Bartal A D, Yarden Y, Schlessinger J, Soreg H. Expression of epidermoid growth factor receptors in human brain tumors. Cancer Res 1984; 44: 753–60
  • Fukushige S, Matsubara K, Yoshida M. Localization of a novel V-erbB-related gene, C-erbB-2, on human chromosome-17 and its amplification in gastric cancer cell line. Mol Cell Biol 1986; 6: 955–8
  • Bargmann C I, Weinberg R A. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc Natl Acad Sci USA 1988; 85: 5394–8
  • Biunno I, Pierotti Pozzi, Mr. Structure and expression of oncogenes in surgical specimens of human breast carcinoma. Br J Cancer 1988; 57: 464–8
  • Varley J M, Swallo J E, Brammar W J. Alterations to either C-erbB-2 or myc protooncogenes in breast carcinomas complete with poor short term prognosis. Oncogene 1987; 1: 423–43
  • Venter D J, Kumar S, Tuzi N L. Overexpression of the human C-erbB-2 oncoprotein in human breast carcinomas. Immunohistochemical assessment correlates with gene amplification. Lancer 1987; 2: 69–71
  • Guerin M, Barrois M, Terrier M J. Overexpression of either C-myc or C-erbB-2/neu protooncogene in human breast carcinomas: correlation with poor prognosis. Oncogene 1988; 3: 21–31
  • Van de Vijver M J, Van de Bresselarr R, Devielee P, Cornelisse C, Peterse J, Nusse R. Amplification of neu (E-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked C-erbA oncogene. Mol Cell Biol 1987; 7: 2019–23
  • Van den Vijver M J, Mooi W J, Wisman P, Peterse J, Nusse R. Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA. Oncogene 1988; 2: 175–8
  • Ali I U, Campbell G, Liderau R. Lack of evidence for the prognostic significance of C-erbB-2 amplification in human breast carcinoma. Oncogene Res 1988; 3: 139–46
  • Agnantis N J, Petraki C, Merkoulatos P, Spandidos D A. Immunohistochemical study of the ras oncogene expression in human breast lesion. Anticancer Res 1986; 6: 1157–60
  • Gusterson B A, Gullick W J, Venter D J. Immunohistochemical localization of C-erbB-2 in human breast carcinomas. Mol Cell Prob 1988; 2: 383–91
  • Berger M S, Locher G W, Saurer S. Correlation of the C-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 1988; 48: 1238–43
  • Van den Vijver M J, Mooi W J, Wisman P, Peterse J, Nusse R. Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA. Oncogene 1988; 2: 175–8
  • Kolata G. Oncogenes give breast cancer prognosis. Science 1987; 235: 160–1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.